COSCIENS Biopharma Inc. (CSCIF) Net margin 2016–2025
COSCIENS Biopharma Inc. (CSCIF) net profit margin by fiscal year — reported net income divided by reported revenue.
-138.1%FY2025 · since FY2016: -2739.7% → -138.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -138.1% | +21.5 pp |
| FY2024 | -159.7% | -110.9 pp |
| FY2023 | -48.8% | -72.5 pp |
| FY2022 | 23.7% | +182.7 pp |
| FY2021 | -159.1% | -18.9 pp |
| FY2020 | -140.1% | +995.6 pp |
| FY2019 | -1135.7% | -1151.3 pp |
| FY2018 | 15.6% | +1835.3 pp |
| FY2017 | -1819.7% | +920.0 pp |
| FY2016 | -2739.7% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice